Next Generation News and Research

RSS

UT Dallas researcher receives NIH grant

For the second time this year, a postdoctoral fellow in UT Dallas' Center for Vital Longevity has earned a prestigious, highly competitive career-development grant from the National Institutes of Health (NIH).

18 Oct 2010

Cempra to present data on solithromycin, TAKSTA at 48th Annual Meeting in Vancouver

Cempra Pharmaceuticals today announced poster presentations on its novel fluoroketolide antibiotic, solithromycin (CEM-101), and the Company's proprietary front-loading oral dosing regimen of sodium fusidate, TAKSTA (CEM-102) at the 48th Annual Meeting of the Infectious Diseases Society of America in Vancouver, British Columbia.

18 Oct 2010

Allegheny expects $0.26 net income for third quarter 2010

Allegheny Technologies Incorporated today provided guidance for the third quarter 2010. ATI expects net income per share for the third quarter 2010 before certain charges to be approximately $0.26.

15 Oct 2010

New comprehensive program for medical electronic device designers

Canon Communications today announced the formation of a comprehensive program to assist designers, developers, and engineering managers involved in the design of electronics-based medical devices. The DesignMED conference and exposition is a collaborative project between the company's Medical Device Group-Medical Electronics Design (MED), EDN, and MD+DI-and its Event Division.

15 Oct 2010

Dr. Nabarro to deliver keynote address at Third McGill Conference on Global Food Security

Dr. David Nabarro, Assistant Secretary-General at the United Nations and co-ordinator of the Secretary-General's High-Level Task Force on the Global Food Security Crisis, will deliver the keynote address at the opening evening of the Third McGill Conference on Global Food Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, 2200 Mansfield St. in Montreal.

13 Oct 2010

IOM report recommends sweeping changes for improving the nursing profession

Still hampered by workforce shortages and barriers that impede their ranks from delivering health care to the full extent of their education and training, nurses may have gotten the much-needed shot in the arm they need to transform their profession with the release of an Institute of Medicine (IOM) report recommending sweeping changes for improving their profession.

13 Oct 2010

New York Stem Cell Foundation names first six NYSCF Investigators

In an expansion of its ongoing effort to promote the next generation of stem cell scientists, The New York Stem Cell Foundation (NYSCF) today named the first six NYSCF Investigators. Each of the NYSCF-Robertson and NYSCF-Helmsley Investigators will receive up to $1.5 million over the next five years to expand their own laboratories, train other scientists and foster innovative high-risk/high reward research to explore the therapeutic potential of stem cells derived from humans and model organisms.

13 Oct 2010

Medical Exchange announces next generation of continuing medical education events

Medical Exchange, an innovative provider of medical education solutions for the health care industry, today announced the next generation of continuing medical education events with the launch of collaborativeCARE Conference (C3).

13 Oct 2010

BIOBASE introduces Genome Trax Next Generation Sequencing solution

BIOBASE announced today that it is entering the Next Generation Sequencing (NGS) market with the launch of a new solution. Genome Trax™ enables researchers to identify genome variations of functional significance by mapping them to known elements such as gene regulatory sites and disease-linked mutations.

13 Oct 2010

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

QIAGEN and Abbott today announced that they have entered into an agreement that significantly strengthens both companies' testing menus for automated in-vitro diagnostic applications in the United States and Canada. Financial terms were not disclosed.

From QIAGEN Manchester Limited 13 Oct 2010

Exiqon introduces on-line microRNA qPCR assay design software

Exiqon A/S, a leading supplier of high-value gene expression analysis products, today announced the extension of the miRCURY LNA microRNA PCR product line with the launch of a novel bioinformatics software for the design of custom qPCR assays for microRNA quantification.

12 Oct 2010

USPTO issues Watson Notice of Allowance for key progesterone patent to treat or prevent preterm birth

Columbia Laboratories, Inc. announced today that the U.S. Patent and Trademark Office (USPTO) has issued Watson Pharmaceuticals, Inc. a Notice of Allowance for a key patent for the use of progesterone to treat or prevent preterm birth. The USPTO issues a Notice of Allowance to report that a patent application has been examined and is allowed for issuance as a patent. The patent is expected to issue within three months upon payment of required fees.

12 Oct 2010

Urgent care clinics find place in market, other health care industry news

Florida Today/USA Today reports that urgent care clinics, "in a growing trend," are seeing consumers increasingly turn to walk-in clinics "and urgent care centers for treatment of minor ailments and injuries instead of trying to squeeze in an appointment with a primary care provider or waiting at a crowded emergency room.

12 Oct 2010

Cerner, MedAssets announce reseller agreement to increase revenue capture

Cerner Corporation and MedAssets announced a reseller agreement that increases the interoperability of Cerner's revenue cycle offerings and gives Cerner clients access to a broader suite of solutions to increase revenue capture, accelerate cash flow and reduce administrative costs.

12 Oct 2010

New phase 2 study shows first-line promise of lung cancer drug PF-299

A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease, investigators reported at the 35th Congress of the European Society for Medical Oncology (ESMO).

11 Oct 2010

ImaginAb and Imanet enter master service agreement for pre-clinical and clinical imaging

ImaginAb, Inc. and Imanet have signed a master service agreement for pre-clinical and clinical imaging. This agreement supports the development strategy for ImaginAb's pipeline of next generation diagnostic imaging agents based on recombinant antibody fragments. The Imanet™ network of Positron Emission Tomography (PET) imaging sites provides assistance in all aspects of PET imaging-based clinical trials: from proof-of-concept radiochemistry to clinical imaging, with more than 40 PET research tracers.

11 Oct 2010

TruTouch secures grant to accelerate development of next-generation technology platform

TruTouch Technologies, a pioneer in non-invasive biometric intoxication detection systems, today announced that it has secured a $438,000 grant to accelerate the development of its next-generation technology platform.

11 Oct 2010

Genentech initiates GDC-0449 Phase II clinical trial in BCC patients

Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).

11 Oct 2010

FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.

11 Oct 2010

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

IntegenX, Inc. today announced that it has been awarded a new contract by the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) to develop an Integrated Sample-to-Sequence (ISS) system for rapid detection and identification of genetically engineered bacteria and viruses, medically relevant bacteria and viruses, and emerging pathogens.

11 Oct 2010

Next Generation News and Research

UT Dallas researcher receives NIH grant

Cempra to present data on solithromycin, TAKSTA at 48th Annual Meeting in Vancouver

Allegheny expects $0.26 net income for third quarter 2010

New comprehensive program for medical electronic device designers

Dr. Nabarro to deliver keynote address at Third McGill Conference on Global Food Security

IOM report recommends sweeping changes for improving the nursing profession

New York Stem Cell Foundation names first six NYSCF Investigators

Medical Exchange announces next generation of continuing medical education events

BIOBASE introduces Genome Trax Next Generation Sequencing solution

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

Exiqon introduces on-line microRNA qPCR assay design software

USPTO issues Watson Notice of Allowance for key progesterone patent to treat or prevent preterm birth

Urgent care clinics find place in market, other health care industry news

Cerner, MedAssets announce reseller agreement to increase revenue capture

New phase 2 study shows first-line promise of lung cancer drug PF-299

ImaginAb and Imanet enter master service agreement for pre-clinical and clinical imaging

TruTouch secures grant to accelerate development of next-generation technology platform

Genentech initiates GDC-0449 Phase II clinical trial in BCC patients

FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News